424B3

 

Filed pursuant to Rule 424(b)(3)

Registration Statement No. 333-260839

Prospectus Supplement No. 6

(To Prospectus dated March 30, 2022)

https://cdn.kscope.io/a9cb42020fbf81c1de8ebac47000b48d-img61650793_0.jpg 

VIVID SEATS INC.

This prospectus supplement updates, amends and supplements the prospectus dated March 30, 2022 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-260839). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

This prospectus supplement is being filed to update, amend, and supplement the information included in the Prospectus with the information contained in our Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on August 9, 2022, which is set forth below.

This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.

Our shares of Class A common stock are listed on The Nasdaq Global Select Market under the symbol “SEAT.” On August 8, 2022, the closing sale price of our Class A common stock was $8.70 per share. Our Vivid Seats Public IPO Warrants are listed on the Nasdaq Global Select Market under the symbol “SEATW.” On August 8, 2022, the closing sale price of our public warrants was $2.10 per warrant.

Investing in shares of our Class A common stock or warrants involves risks that are described in the “Risk Factors” section beginning on page 5 of the Prospectus and under similar headings in any further amendments or supplements to the Prospectus.

Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is August 9, 2022

 

 

 

 


 

ma

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-40926

 

Vivid Seats Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

86-3355184

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

111 N. Canal Street

Suite 800

Chicago, Illinois

 

 

60606

(Address of principal executive offices)

(Zip Code)

(312) 291-9966

Registrant’s telephone number, including area code

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Title of each class

 

Trading

Symbol(s)

 

 

Name of each exchange on which registered

 Class A common stock, par value $0.0001 per share

 

SEAT

 

The Nasdaq Stock Market LLC

Warrants to purchase one share of Class A common stock

 

SEATW

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 

Non-accelerated filer

 

 

Smaller reporting company

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 31, 2022, the registrant had 82,041,142 shares of Class A common stock, $0.0001 par value per share, outstanding and 118,200,000 shares of Class B common stock, $0.0001 par value per share, outstanding.

 

 

 


TABLE OF CONTENTS

 

 

 

Page

 

 

 

 

Forward-Looking Statements

1

PART I.

FINANCIAL INFORMATION

3

 

 

 

Item 1.

Financial Statements (Unaudited)

3

 

Condensed Consolidated Balance Sheets

3

 

Condensed Consolidated Statements of Operations

4

 

Condensed Consolidated Statements of Comprehensive Income (Loss)

5

 

Condensed Consolidated Statements of Deficit

6

 

Condensed Consolidated Statements of Cash Flows

8

 

Notes to Condensed Consolidated Financial Statements

9

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

25

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

35

Item 4.

Controls and Procedures

35

 

 

 

PART II.

OTHER INFORMATION

36

 

 

 

Item 1.

Legal Proceedings

36

Item 1A.

Risk Factors

36

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

36

Item 3.

Defaults Upon Senior Securities

37

Item 4.

Mine Safety Disclosures

37

Item 5.

Other Information

37

Item 6.

Exhibits

38

Signatures

40

 

 


forward-looking statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements regarding future events and the future results of Vivid Seats Inc. that are based on our current expectations, estimates, forecasts and projections about the industries in which we operate and the beliefs and assumptions of our management. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Words such as “expect,” “anticipate,” “target,” “goal,” “project,” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “likely,” “may,” “designed,” “would,” “future,” “can,” “could,” and other similar expressions which are predictions of, indicate future events and trends or which do not relate to historical matters, are intended to identify such forward-looking statements. These statements involve a number of risks, uncertainties and assumptions that are difficult to predict.

For example, we may use forward-looking statements when addressing topics such as:

the COVID-19 pandemic, its duration, its impact on our business, results of operations, financial condition, liquidity, use of our borrowings, business practices, operations, suppliers, third-party service providers, customers, employees, industry, ability to meet future performance obligations and ability to efficiently implement advisable safety precautions;
our ability to raise financing in the future;
our future financial performance;
our success in retaining or recruiting, or changes required in, our officers, key employees or directors;
our ability to pay dividends on our Class A common stock on the terms currently contemplated or at all; and
factors relating to our business, operations and financial performance, including, but not limited to:
o
the impact of the pandemic on our business and the industries in which we operate;
o
our ability to compete in the ticketing industry;
o
our ability to maintain relationships with buyers, sellers and distribution partners;
o
our ability to continue to improve our platform and maintain and enhance our brand;
o
the impact of extraordinary events or adverse economic conditions on discretionary consumer and corporate spending or on the supply and demand of live events;
o
our ability to comply with domestic regulatory regimes;
o
our ability to successfully defend against litigation;
o
our ability to maintain the integrity of our information systems and infrastructure, and to mitigate possible cyber security risks;
o
our ability to generate sufficient cash flows or raise additional capital necessary to fund our operations; and
o
other factors detailed under the section entitled “Risk Factors.”

1


 

Actual results may differ materially and adversely from those expressed in any forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document, or in the case of statements incorporated by reference, on the date of the document incorporated by reference. While we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

Factors that might cause or contribute to such differences include, but are not limited to, those discussed in this Quarterly Report on Form 10-Q, under the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the Securities and Exchange Commission (the “SEC”) on March 15, 2022, under the section entitled “Risk Factors,” in our press releases, and in our other filings with the SEC.

Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this Quarterly Report on Form 10-Q, whether as a result of new information, future events, or risks. New information, future events, or risks may cause the forward-looking events we discuss in this report not to occur.

2


VIVID SEATS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data) (Unaudited)

 

 

 

 

June 30,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

287,811

 

 

$

489,530

 

Restricted cash

 

 

219

 

 

 

280

 

Accounts receivable – net

 

 

44,373

 

 

 

36,124

 

Inventory – net

 

 

21,202

 

 

 

11,773

 

Prepaid expenses and other current assets

 

 

59,306

 

 

 

72,504

 

Total current assets

 

 

412,911

 

 

 

610,211

 

Property and equipment – net

 

 

3,293

 

 

 

1,082

 

Right-of-use assets – net

 

 

8,806

 

 

 

 

Intangible assets – net

 

 

80,067

 

 

 

78,511

 

Goodwill

 

 

715,258

 

 

 

718,204

 

Other non-current assets

 

 

2,717

 

 

 

787

 

Total assets

 

$

1,223,052

 

 

$

1,408,795

 

Liabilities and shareholders’ deficit

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

191,454

 

 

$

191,201

 

Accrued expenses and other current liabilities

 

 

246,157

 

 

 

281,156

 

Deferred revenue

 

 

32,657

 

 

 

25,139

 

Current maturities of long-term debt – net

 

 

2,750

 

 

 

 

Total current liabilities

 

 

473,018

 

 

 

497,496

 

Long-term debt – net

 

 

265,902

 

 

 

460,132

 

Long-term lease liabilities

 

 

9,386

 

 

 

 

Other liabilities

 

 

17,414

 

 

 

25,834

 

Total long-term liabilities

 

 

292,702

 

 

 

485,966

 

Commitments and contingencies (Note 12)

 

 

 

 

 

 

Redeemable noncontrolling interests

 

 

882,954

 

 

 

1,286,016

 

 

 

 

 

 

 

 

Shareholders' deficit

 

 

 

 

 

 

Class A common stock, $0.0001 par value; 500,000,000 shares authorized at June 30, 2022 and December 31, 2021; 79,241,032 and 79,091,871 issued and outstanding at June 30, 2022 and December 31, 2021, respectively

 

 

8

 

 

 

8

 

Class B common stock, $0.0001 par value; 250,000,000 shares authorized, 118,200,000 issued and outstanding at June 30, 2022 and December 31, 2021

 

 

12

 

 

 

12

 

Additional paid-in capital

 

 

606,238

 

 

 

182,091

 

Accumulated deficit

 

 

(1,031,880

)

 

 

(1,042,794

)

Total Shareholders' deficit

 

 

(425,622

)

 

 

(860,683

)

Total liabilities, Redeemable noncontrolling interests, and Shareholders' deficit

 

$

1,223,052

 

 

$

1,408,795

 

The accompanying notes are an integral part of these financial statements.

3


VIVID SEATS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except for per share data) (Unaudited)

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenues

 

$

147,694

 

 

$

115,498

 

 

$

278,466

 

 

$

139,612

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues (exclusive of depreciation and amortization shown separately below)

 

 

32,422

 

 

 

19,986

 

 

 

64,586

 

 

 

23,911

 

Marketing and selling

 

 

59,412

 

 

 

46,422

 

 

 

113,640

 

 

 

54,377

 

General and administrative

 

 

36,207

 

 

 

29,106

 

 

 

65,482

 

 

 

44,977

 

Depreciation and amortization

 

 

1,726

 

 

 

500

 

 

 

3,111

 

 

 

795

 

Income from operations

 

 

17,927

 

 

 

19,484

 

 

 

31,647

 

 

 

15,552

 

Other (income) expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense – net

 

 

2,699

 

 

 

16,839

 

 

 

6,641

 

 

 

33,158

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

4,285

 

 

 

 

Other income

 

 

(8,832

)

 

 

 

 

 

(6,553

)

 

 

 

Income (loss) before income taxes

 

 

24,060

 

 

 

2,645

 

 

 

27,274

 

 

 

(17,606

)

Income tax expense

 

 

 

 

 

 

 

 

76

 

 

 

 

Net income (loss)

 

 

24,060

 

 

 

2,645

 

 

 

27,198

 

 

 

(17,606

)

Net income (loss) attributable to Hoya Intermediate, LLC shareholders prior to reverse recapitalization

 

 

 

 

 

2,645

 

 

 

 

 

 

(17,606

)

Net income attributable to redeemable noncontrolling interests

 

 

14,405

 

 

 

 

 

 

16,284

 

 

 

 

Net income attributable to Class A Common Stockholders

 

$

9,655

 

 

$

 

 

$

10,914

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income per Class A Common Stock(1):

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.12

 

 

 

 

 

$

0.14

 

 

 

 

Diluted

 

$

0.12

 

 

 

 

 

$

0.14

 

 

 

 

Weighted average Class A Common Stock outstanding(1):

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

79,256,354

 

 

 

 

 

 

79,204,430

 

 

 

 

Diluted

 

 

79,259,017

 

 

 

 

 

 

79,737,582

 

 

 

 

(1) There were no shares of Class A Common Stock outstanding prior to October 18, 2021. Therefore, no income (loss) per share information has been presented for any period prior to that date.

The accompanying notes are an integral part of these financial statements.

4


VIVID SEATS INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in thousands) (Unaudited)

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net income (loss)

 

$

24,060

 

 

$

2,645

 

 

$

27,198

 

 

$

(17,606

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain on derivative instruments

 

 

 

 

 

270

 

 

 

 

 

 

513

 

Comprehensive income (loss), net of taxes

 

$

24,060

 

 

$

2,915

 

 

$

27,198

 

 

$

(17,093

)

Comprehensive income (loss) attributable to Hoya Intermediate, LLC shareholders prior to reverse recapitalization

 

 

 

 

 

2,915

 

 

 

 

 

 

(17,093

)

Comprehensive income attributable to redeemable noncontrolling interests

 

 

14,405

 

 

 

 

 

 

16,284

 

 

 

 

Comprehensive income attributable to Class A Common Stockholders

 

$

9,655

 

 

$

 

 

$

10,914

 

 

$

 

The accompanying notes are an integral part of these financial statements.

5


VIVID SEATS INC.

CONDENSED CONSOLIDATED STATEMENTS OF DEFICIT

(in thousands, except share/unit data) (Unaudited)
 

 

 

 

Redeemable Senior preferred units

 

 

Redeemable Preferred units

 

 

 

Common units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Units

 

 

Amount

 

 

Units

 

 

Amount

 

 

 

Units

 

 

Amount

 

 

Additional paid-in capital

 

 

Accumulated deficit

 

 

Accumulated other comprehensive income (loss)

 

 

Total members' deficit

 

Balances at January 1, 2021

 

 

100

 

 

$

218,288

 

 

 

100

 

 

$

9,939

 

 

 

 

100

 

 

$

 

 

$

755,716

 

 

$

(1,026,675

)

 

$

(822

)

 

$

(271,781

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(20,251

)

 

 

 

 

 

(20,251

)

Unrealized gain on derivative instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

243

 

 

 

243

 

Deemed contribution from former parent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,091

 

 

 

 

 

 

 

 

 

1,091

 

Accretion of senior preferred units

 

 

 

 

 

6,822

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,822

)

 

 

 

 

 

 

 

 

(6,822

)

Balances at March 31, 2021

 

 

100

 

 

$

225,110

 

 

 

100

 

 

$

9,939

 

 

 

 

100

 

 

$

 

 

$

749,985

 

 

$

(1,046,926

)

 

$

(579

)

 

$

(297,520

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,645

 

 

 

 

 

 

2,645

 

Unrealized gain on derivative instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

270

 

 

 

270

 

Deemed contribution from former parent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,183

 

 

 

 

 

 

 

 

 

1,183

 

Accretion of senior preferred units

 

 

 

 

 

6,821

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,821

)

 

 

 

 

 

 

 

 

(6,821

)

Balances at June 30, 2021

 

 

100

 

 

$

231,931

 

 

 

100

 

 

$

9,939

 

 

 

 

100

 

 

$

 

 

$

744,347

 

 

$

(1,044,281

)

 

$

(309

)

 

$

(300,243

)

 

6


VIVID SEATS INC.

CONDENSED CONSOLIDATED STATEMENTS OF DEFICIT

(in thousands, except share/unit data) (Unaudited)
 

 

 

 

 

 

Class A Common Stock

 

 

Class B Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Additional paid-in capital

 

 

Accumulated deficit

 

 

Total shareholders' deficit

 

Balances at January 1, 2022

 

$

1,286,016

 

 

 

79,091,871

 

 

$

8

 

 

 

118,200,000

 

 

$

12

 

 

$

182,091

 

 

$

(1,042,794

)

 

$

(860,683

)

Net income

 

 

1,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,259

 

 

 

1,259

 

Issuance of shares

 

 

 

 

 

75,072

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deemed contribution from former parent

 

 

691

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

463

 

 

 

 

 

 

463

 

Equity-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,443

 

 

 

 

 

 

2,443

 

Subsequent remeasurement of Redeemable noncontrolling interests

 

 

18,706

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(18,706

)

 

 

 

 

 

(18,706

)

Balances at March 31, 2022

 

$

1,307,292

 

 

 

79,166,943

 

 

$

8

 

 

 

118,200,000

 

 

$

12

 

 

$

166,291

 

 

$

(1,041,535

)

 

$

(875,224

)

Net income

 

 

14,405

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,655

 

 

 

9,655

 

Issuance of shares

 

 

 

 

 

74,089

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deemed contribution from former parent

 

 

699

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

468

 

 

 

 

 

 

468

 

Equity-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,145

 

 

 

 

 

 

4,145

 

Distributions to non-controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,108

)

 

 

 

 

 

(4,108

)

Subsequent remeasurement of Redeemable noncontrolling interests

 

 

(439,442

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

439,442

 

 

 

 

 

 

439,442

 

Balances at June 30, 2022

 

$

882,954

 

 

 

79,241,032

 

 

$

8

 

 

 

118,200,000

 

 

$

12

 

 

$

606,238

 

 

$

(1,031,880

)

 

$

(425,622

)

 

The accompanying notes are an integral part of these financial statements.

 

7


VIVID SEATS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) (Unaudited)

 

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

Cash flows from operating activities

 

 

 

 

 

 

Net income (loss)

 

$

27,198

 

 

$

(17,606

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

3,111

 

 

 

795

 

Amortization of deferred financing costs and interest rate cap

 

 

575

 

 

 

2,680

 

Equity-based compensation expense

 

 

8,909

 

 

 

2,274

 

Loss on extinguishment of debt

 

 

4,285

 

 

 

 

Change in fair value of warrants

 

 

(6,553

)

 

 

 

Interest expense paid-in-kind

 

 

 

 

 

16,164

 

Amortization of leases

 

 

1,177

 

 

 

 

Change in assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(8,171

)

 

 

(16,943

)

Inventory

 

 

(9,429

)

 

 

(14,250

)

Prepaid expenses and other current assets

 

 

13,412

 

 

 

(38,154

)

Accounts payable

 

 

(638

)

 

 

174,978

 

Accrued expenses and other current liabilities

 

 

(38,014

)

 

 

62,070

 

Deferred revenue

 

 

7,518

 

 

 

10,661

 

Other assets and liabilities

 

 

(1,974

)

 

 

327

 

Net cash provided by operating activities

 

 

1,406

 

 

 

182,996

 

Cash flows from investing activities

 

 

 

 

 

 

Purchases of property and equipment

 

 

(1,392

)

 

 

(250

)

Purchases of personal seat licenses

 

 

(137

)

 

 

(76

)

Investments in developed technology

 

 

(5,394

)

 

 

(3,886

)

Cash adjustment in acquisition

 

 

(8

)

 

 

 

Net cash used in investing activities

 

 

(6,931

)

 

 

(4,212

)

Cash flows from financing activities

 

 

 

 

 

 

Payments of June 2017 First Lien Loan

 

 

(465,712

)

 

 

(3,206

)

Proceeds from February 2022 First Lien Loan

 

 

275,000

 

 

 

 

Payments of deferred financing costs and other debt-related costs

 

 

(4,856

)

 

 

 

Payments of February 2022 First Lien Loan

 

 

(687

)

 

 

 

Net cash used in financing activities

 

 

(196,255

)

 

 

(3,206

)

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

 

(201,780

)

 

 

175,578

 

Cash, cash equivalents, and restricted cash – beginning of period

 

 

489,810

 

 

 

285,337

 

Cash, cash equivalents, and restricted cash – end of period

 

$

288,030

 

 

$

460,915

 

Supplemental disclosure of cash flow information: